ATXN3 and Huntington disease: Later, the TR-FRET-based immunoassays were further developed into ultra-sensitive single-molecule counting (SMC) immunoassays in order to be able to quantify fmol protein amounts in CSF and peripheral blood of HD and SCA3 mutation carrier, too [46, 47].